Cole picked to lead bioscience association

DENVER – Derek Cole was appointed chairman of the board of the Colorado BioScience Association at the trade group’s annual meeting Wednesday.

Cole, president of Investor Relations Advisory Solutions LLC in Broomfield, takes over chairman duties from Steve Orndorff, chief executive of Broomfield-based Ariel Pharmaceuticals Inc.

Cole has 22 years of experience in the capital-markets and corporate-planning sectors. He has 16 years of dedicated investor relations, corporate communications and media relations experience focused on supporting the development of private, small- and mid-cap companies.

New officers on the board include vice chairman Mark Spiecker, CEO, Sharklet Technologies Inc. in Aurora; treasurer Jim Wilson, partner, Ernst & Young in Denver; and secretary Lisa Drake, director of government affairs for  Monsanto Co. in Englewood.

New board members include Bill Marshall, president and CEO of miRagen Inc. in Boulder; Chris Myatt, co-founder and CEO of MBio Diagnostics Inc. in Boulder; Bob Reddy, director of global marketing, Medtronic Navigation Inc. in Louisville; Brenda Fielding, executive vice president of regulatory and strategic development at Clinipace Worldwide in Boulder; Scott Larson, senior vice president of Terumo BCT in Lakewood; and Brett Lund, executive vice president of Gevo Inc. in Englewood.

on Facebook on LinkedIn